[Treatment of prostatic hypertrophy with 19-norhydroxyprogesterone caproate].
D000368:Aged; D000818:Animals; D002208:Caproates / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D008875:Middle Aged; D009929:Organ Size; D011278:Pregnanes / Q000494:pharmacology / Q000627:therapeutic use*; D011467:Prostate / Q000187:drug effects / Q000473:pathology; D011470:Prostatic Hyperplasia / Q000188:drug therapy*; D051381:Rats; D012669:Seminal Vesicles / Q000187:drug effects / Q000473:pathology; D013737:Testis / Q000187:drug effects / Q000473:pathology
D002208:Caproates; D011278:Pregnanes